Cargando…

Emergencies and critical issues in Parkinson’s disease

Complications from Parkinson’s disease may develop over the disease course, sometimes unexpectedly, and require prompt or even urgent medical intervention. The most common are associated with aggravation of motor symptoms; serious non-motor complications, such as psychosis, orthostatic hypotension o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Simonet, Cristina, Tolosa, Eduardo, Camara, Ana, Valldeoriola, Francesc
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7029239/ https://www.ncbi.nlm.nih.gov/pubmed/31427383 http://dx.doi.org/10.1136/practneurol-2018-002075

Ejemplares similares

Transcriptome analysis in LRRK2 and idiopathic Parkinson’s disease at different glucose levels
por: Fernández-Santiago, Rubén, et al.
Publicado: (2021)

Domotics, Smart Homes, and Parkinson’s Disease
por: Simonet, Cristina, et al.
Publicado: (2021)

How I do it — asleep DBS placement for Parkinson’s disease
por: Roldan, Pedro, et al.
Publicado: (2023)

Nonmotor Symptoms in LRRK2 G2019S Associated Parkinson’s Disease
por: Gaig, Carles, et al.
Publicado: (2014)

Differential diagnosis between Parkinson's disease and essential tremor using the smartphone's accelerometer
por: Barrantes, Sergi, et al.
Publicado: (2017)

Validation study of the Parkinson’s Fatigue Scale in advanced Parkinson’s disease
por: Martinez-Martin, Pablo, et al.
Publicado: (2019)

A Spanish Consensus on the Use of Safinamide for Parkinson’s Disease in Clinical Practice
por: Pagonabarraga, Javier, et al.
Publicado: (2020)

A tool to improve pre-selection for deep brain stimulation in patients with Parkinson’s disease
por: Wächter, Tobias, et al.
Publicado: (2010)

Increased Phospho‐AKT in Blood Cells from LRRK2 G2019S Mutation Carriers
por: Garrido, Alicia, et al.
Publicado: (2022)

Psychometric Properties of the Apathy Scale in Advanced Parkinson's Disease
por: Wetmore, John B., et al.
Publicado: (2019)

Differential Phospho‐Signatures in Blood Cells Identify LRRK2 G2019S Carriers in Parkinson's Disease
por: Garrido, Alicia, et al.
Publicado: (2022)

Patterns of cortical thinning in nondemented Parkinson's disease patients
por: Uribe, Carme, et al.
Publicado: (2016)

l‐Dopa/carbidopa intestinal gel and subthalamic nucleus stimulation: Effects on cognition and behavior
por: Valldeoriola, Francesc, et al.
Publicado: (2017)

The cost-effectiveness of deep brain stimulation in combination with best medical therapy, versus best medical therapy alone, in advanced Parkinson’s disease
por: Eggington, Simon, et al.
Publicado: (2013)

Cognitive Behavioral Therapy Plus a Serious Game as a Complementary Tool for a Patient With Parkinson Disease and Impulse Control Disorder: Case Report
por: Mena-Moreno, Teresa, et al.
Publicado: (2022)

Differential Progression of Regional Hippocampal Atrophy in Aging and Parkinson’s Disease
por: Uribe, Carme, et al.
Publicado: (2018)

Safinamide in the treatment pathway of Parkinson’s Disease: a European Delphi Consensus
por: Stocchi, Fabrizio, et al.
Publicado: (2022)

Gray/White Matter Contrast in Parkinson’s Disease
por: Uribe, Carme, et al.
Publicado: (2018)

Discriminating cognitive status in Parkinson’s disease through functional connectomics and machine learning
por: Abós, Alexandra, et al.
Publicado: (2017)

Sex Differences in Brain and Cognition in de novo Parkinson's Disease
por: Oltra, Javier, et al.
Publicado: (2022)

The motor prodromes of parkinson’s disease: from bedside observation to large-scale application
por: Simonet, C., et al.
Publicado: (2019)

Acalculous cholecystitis associated with levodopa-carbidopa intestinal infusion therapy: A case report
por: Torres, Viviana, et al.
Publicado: (2022)

Cirugía de los trastornos del movimiento
por: Valldeoriola Serra, Francesc
Publicado: (2007)

Structural Brain Correlations of Visuospatial and Visuoperceptual Tests in Parkinson’s Disease
por: Garcia-Diaz, Anna Isabel, et al.
Publicado: (2017)

SARS-CoV-2, COVID-19 and Parkinson’s Disease—Many Issues Need to Be Clarified—A Critical Review
por: Goerttler, Tsepo, et al.
Publicado: (2022)

Disrupted Mitochondrial and Metabolic Plasticity Underlie Comorbidity between Age-Related and Degenerative Disorders as Parkinson Disease and Type 2 Diabetes Mellitus
por: Juárez-Flores, Diana Luz, et al.
Publicado: (2020)

Diagnosis and management of Parkinson's disease dementia
por: Poewe, W, et al.
Publicado: (2008)

Emerging Immunotherapies for Parkinson Disease
por: Zella, Samis M. A., et al.
Publicado: (2018)

People with Parkinson's disease and housing issues: A scoping review
por: Iwarsson, Susanne, et al.
Publicado: (2022)

Colonic Oxidative and Mitochondrial Function in Parkinson's Disease and Idiopathic REM Sleep Behavior Disorder
por: Morén, C., et al.
Publicado: (2017)

The Emerging Role of the Lysosome in Parkinson’s Disease
por: Navarro-Romero, Alba, et al.
Publicado: (2020)

The emerging role of autophagy in Parkinson's disease
por: Cheung, Zelda H, et al.
Publicado: (2009)

Brain atrophy pattern in de novo Parkinson’s disease with probable RBD associated with cognitive impairment
por: Oltra, Javier, et al.
Publicado: (2022)

Patient and caregiver outcomes with levodopa-carbidopa intestinal gel in advanced Parkinson’s disease
por: Valldeoriola, Francesc, et al.
Publicado: (2021)

Present and Future of Parkinson’s Disease in Spain: PARKINSON-2030 Delphi Project
por: Santos García, Diego, et al.
Publicado: (2021)

Bringing Advanced Therapies for Parkinson’s Disease to the Clinic: An Analysis of Ethical Issues
por: Hug, Kristina
Publicado: (2021)

The treatment of Parkinson's disease with deep brain stimulation: current issues
por: Moldovan, Alexia-Sabine, et al.
Publicado: (2015)

Emerging Infectious Diseases: Trends and Issues
por: Larson, Elaine
Publicado: (2003)

Occupational lifestyle diseases: An emerging issue
por: Sharma, Mukesh, et al.
Publicado: (2009)

Erratum: Pagonabarraga, J.; et al. A Spanish Consensus on the Use of Safinamide for Parkinson’s Disease in Clinical Practice. Brain Sci. 2020, 10, 176
por: Pagonabarraga, Javier, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_1ogai18qs7qa39on1n1f877ua4